Modular JIT Bioprocess Platform for Local Vaccine Manufacturing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current manufacturing strategies for biologicals, such as vaccines, face challenges in continuous production, high costs, and logistical issues due to stockpiling and transportation, especially in areas lacking infrastructure and trained manpower, necessitating a Just-In-Time (JIT) manufacturing solution for small-scale, cost-effective production.
Innovation Solution
A computing-based, integrated platform system for JIT bioprocess manufacturing, incorporating a computing device with a power source, networking capabilities, and plug-and-play modules for fermentation, formulation, and quality control, allowing for autonomous operation, minimal human intervention, and scalability to produce biologicals like vaccines efficiently and cost-effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If biologicals are stockpiled for future use, then availability is improved, but storage costs and logistics complexity increase
Solution Approach 1:
The system performs preliminary action by establishing automated manufacturing capabilities at distribution locations, enabling local production when needed rather than relying on pre-stockpiled supplies. The automated systems are prepared in advance and can be activated immediately upon receipt of orders, eliminating the need for long-term stockpiling while maintaining availability.
Solution Approach 2:
The patent implements self-service through automated manufacturing systems that operate autonomously at distribution locations. These systems automatically receive orders, manufacture the required biologicals using local resources, and fulfill demands without requiring complex centralized logistics and distribution chains, thereby reducing logistics complexity while maintaining reliability.
2Reliability
If biologicals are transported to distribution locations, then availability is improved, but transportation costs and time increase
Solution Approach 1:
The patent applies segmentation by decentralizing manufacturing to local distribution locations rather than centralizing production and transporting finished goods. Each location has its own automated manufacturing system that produces biologicals locally, eliminating long-distance transportation and reducing distribution time while maintaining availability through local self-sufficiency.
Solution Approach 2:
The patent inverts the traditional logistics model by bringing manufacturing to the point of consumption rather than transporting products from production centers. This reversal eliminates transportation time and costs associated with moving biologicals over long distances, while automated systems ensure availability through immediate local production capability.
3Ease of manufacture
If mass production is used, then cost is reduced, but flexibility for small scale production is worsened
Solution Approach 1:
The patent implements dynamics through automated manufacturing systems that can dynamically adjust production volume based on actual demand. These systems transition from static mass production models to flexible, demand-responsive operations, maintaining cost-effectiveness through automation while adapting production scales to match actual needs, thereby achieving both low cost and high flexibility.
Solution Approach 2:
The patent applies parameter changes by enabling automated systems to vary production parameters such as batch size, production rate, and resource allocation based on real-time demand signals. This allows the system to operate efficiently across different production scales, maintaining cost-effectiveness through automation while achieving the adaptability needed for both small-scale and large-scale production as conditions require.
4Ease of manufacture
If automated systems are deployed, then labor costs are reduced, but initial investment and complexity increase
Solution Approach 1:
The patent applies universality by designing automated manufacturing systems with standardized, modular components that can perform multiple functions. These universal systems handle various manufacturing tasks using integrated automation, reducing the need for specialized equipment and complex human intervention. The standardized architecture lowers initial investment while maintaining labor cost benefits, effectively balancing complexity reduction with automation advantages.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, cost-effective, and logistically feasible production of biologicals, reducing the need for stockpiling and minimizing distribution challenges, while ensuring regulatory compliance and high throughput, even in resource-limited areas, with the ability to scale production as needed.
Implementation Method 1
The fermentation module receives a substrate and transforms the substrate into a product through fermentation
Data Source
AI summary
An integrated platform system controlled with hardware and software for just-in-time, local manufacturing is disclosed. System hardware may include a fermentation system, a cross-flow system, a disposable formulation system, a robotic fill-finish system, and a quality control test and release system.